Atopic dermatitis of mild to moderate severity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women who are between 20 and 80 years old at the time of obtaining consent. 2) Those who are in charge of cleaning their homes, have a habit of cleaning with an electric vacuum cleaner, and are able to clean their homes early every morning. 3) Those who are able to come to the examination according to the set schedule. 4) Patients with mild to moderate atopic dermatitis who have stable symptoms (no change in medication, regardless of whether or not the patient has been to the hospital (to prevent changes in skin characteristics)). Patients with chronic diseases such as internal medicine that require regular visits to the hospital and treatment with oral medication will be included in the selection criteria, and changes in medication will be possible, although reporting will be required. 5) Those who have received sufficient explanation and written consent of their own free will to participate in this clinical study.
Exclusion criteria
Exclusion criteria: 1) Persons who are active during the night and sleep during the day 2) Persons who are judged by the principal investigator or sub-investigator to be inappropriate as research subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Group differences in the change in IgE between the initial value and the 24th week of use. | — |
Secondary
| Measure | Time frame |
|---|---|
| The initial values for View Allergy39 will be the values on the day of the measurement selected for the study. View Allergy39 (only 18 items related to inhalation), TARC, eosinophils, and visual examination score at the dermatologist interview. | — |
Countries
Japan
Contacts
KSK Laboratories,Inc. representative